Aravive's average Accounts Receivable for the
three
months ended in Sep. 2023 was $0.00 Mil. Aravive's Revenue for the
three
months ended in Sep. 2023 was $2.76 Mil.
Hence, Aravive's Days Sales Outstanding for the
three
months ended in Sep. 2023 was 0.00.
The historical rank and industry rank for Aravive's Days Sales Outstanding or its related term are showing as below:
ARAV'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 0 Med: 0 Max: 313.08
Current: 313.08
During the past 11 years, Aravive's highest Days Sales Outstanding was 313.08. The lowest was 0.00. And the median was 0.00.
ARAV's Days Sales Outstanding is not ranked
in the Biotechnology industry.
Industry Median: 71.97
vs ARAV: 313.08
Aravive's Days Sales Outstanding
declined
from Sep. 2022 (110.47) to Sep. 2023 (0.00).
Warning Sign:
If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.
Aravive Days Sales Outstanding Historical Data
The historical data trend for Aravive's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Aravive's Days Sales Outstanding
For the Biotechnology subindustry, Aravive's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aravive's Days Sales Outstanding Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Aravive's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Aravive's Days Sales Outstanding falls into.
Aravive Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aravive (NAS:ARAV) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Aravive Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Aravive's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Aravive Inc is a clinical-stage biopharmaceutical company. It focuses on developing treatments designed to halt the progression of life-threatening diseases, including cancer and fibrosis. The company pipeline product Batiraxcept (formerly AVB-500) which is an ultra-high affinity decoy protein that binds to GAS6 and thereby prevents AXL signaling to inhibit metastasis and tumor growth and restore sensitivity to anti-cancer agents. Batiraxcept is currently being evaluated in multiple clinical trials.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ARAV has been successfully added to your 